Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Pinus Strobus Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Eastern White Pine allergies through skin testing and subcutaneous immunotherapy.
Name
Pinus Strobus Pollen
Raw Name
PINUS STROBUS POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
22
Variant Count
23
Last Verified
February 17, 2026
About Pinus Strobus Pollen
Pinus Strobus Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Eastern White Pine allergies through skin testing and subcutaneous immunotherapy.
Detailed information about Pinus Strobus Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Pinus Strobus Pollen.
The use of allergenic extracts in the United States is governed by the FDA’s Center for Biologics Evaluation and Research (CBER). Many of these extracts have a long history of use, often predating modern clinical trial requirements, and are maintained under specific regulatory frameworks for biological products. The primary clinical utility of Pinus Strobus Pollen is twofold: it serves as a diagnostic reagent for skin prick testing (to identify pine pollen sensitivity) and as the active ingredient in subcutaneous immunotherapy (SCIT), commonly known as 'allergy shots.'
To understand how Pinus Strobus Pollen works, one must first understand the mechanism of allergic sensitization and desensitization. When a patient is allergic to Eastern White Pine, their immune system has mistakenly identified the pollen's proteins as harmful invaders. This leads to the production of Immunoglobulin E (IgE) antibodies specific to Pinus strobus. These IgE antibodies bind to the surface of mast cells and basophils. Upon subsequent exposure to the pollen, the allergens cross-link the IgE on these cells, triggering the release of inflammatory mediators like histamine, leukotrienes, and cytokines. This cascade results in the classic symptoms of hay fever: sneezing, itching, and congestion.
When used diagnostically, a tiny amount of Pinus Strobus Pollen extract is introduced into the skin. If the patient is sensitized, a localized 'wheal and flare' reaction occurs within minutes, confirming the presence of specific IgE. When used therapeutically in immunotherapy, the mechanism is more complex. By injecting gradually increasing doses of the extract over several months, the healthcare provider attempts to 'retrain' the immune system. This process, known as desensitization, involves a shift from a Th2-dominated immune response (which promotes allergy) to a Th1-dominated response. It also induces the production of 'blocking antibodies' (IgG4), which can intercept the allergen before it reaches the IgE on mast cells. Furthermore, it promotes the activity of regulatory T-cells (Tregs) that suppress the allergic inflammation at its source.
Unlike traditional small-molecule drugs, the pharmacokinetics of Pinus Strobus Pollen (an allergenic extract) do not follow standard patterns of absorption, distribution, metabolism, and excretion (ADME).
Pinus Strobus Pollen is FDA-indicated for the following uses:
Off-label use of allergenic extracts is rare, as their application is highly specific to the identified allergen. However, they are occasionally used in research settings to study the mechanisms of airway inflammation.
Pinus Strobus Pollen is available in several liquid concentrations for parenteral (non-oral) use:
> Important: Only your healthcare provider can determine if Pinus Strobus Pollen is right for your specific condition. The administration of this extract must be performed by a qualified medical professional prepared to treat emergency allergic reactions.
Dosage for Pinus Strobus Pollen is highly individualized and is not based on a standard 'one size fits all' milligram amount. Instead, it is based on the patient's sensitivity and the concentration of the extract.
Pinus Strobus Pollen is used in children, but the dosage must be approached with extreme caution. Children are often more reactive than adults. The dosing logic (build-up and maintenance) remains the same as in adults, but the starting concentration may be even lower if the child is highly sensitive. Immunotherapy is generally not recommended for children under the age of 5, as they may be unable to communicate the early symptoms of a systemic reaction.
No specific dose adjustments are required for renal (kidney) impairment, as the extract is not cleared through the kidneys in a manner that would cause toxicity.
No specific dose adjustments are required for hepatic (liver) impairment.
Elderly patients may be at higher risk for complications if a systemic reaction occurs, particularly if they have underlying cardiovascular disease. Healthcare providers may choose a more conservative build-up schedule.
Pinus Strobus Pollen extracts are NEVER for self-administration at home. They must be administered in a clinical setting by a healthcare provider.
If a dose is missed during the build-up phase, the healthcare provider may need to repeat the previous dose or even reduce the dose, depending on how much time has passed. If a maintenance dose is missed by more than a week or two, the dose is often reduced for the next injection to ensure safety.
An 'overdose' in the context of allergenic extracts means receiving a dose higher than the patient's current tolerance level. This can occur due to a calculation error or if the patient's sensitivity has increased (e.g., during peak pine pollen season).
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients receiving Pinus Strobus Pollen will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Pinus Strobus Pollen and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Pinus Strobus Pollen, as it is a natural protein extract. The primary long-term risk is the development of a new sensitivity, though this is rare. Most long-term effects of immunotherapy are positive, leading to a permanent reduction in allergy symptoms and a decreased risk of developing asthma.
Pinus Strobus Pollen, like all allergenic extracts, carries a significant warning regarding Anaphylaxis.
Report any unusual symptoms to your healthcare provider. Even a large local reaction should be reported, as it may be a precursor to a systemic reaction at the next dose level.
Pinus Strobus Pollen is a potent biological product. It is not a 'medication' in the traditional sense but an immunological challenge. Patients must be in good health at the time of the injection. If you have a fever, a respiratory infection, or an active asthma flare-up, your healthcare provider will likely postpone your injection.
No FDA black box warnings for Pinus Strobus Pollen specifically are listed in the same format as pharmaceutical drugs, but the class-wide warning for allergenic extracts is universally applied. It states that allergenic extracts are intended for use only by physicians experienced in administering allergenic extracts and in managing the potentially fatal systemic reactions that may occur. Epinephrine must be available for immediate use.
There are no standard lab tests (like liver or kidney panels) required for Pinus Strobus Pollen. Instead, monitoring is clinical:
Most patients can drive after the 30-minute observation period. However, if a patient experiences significant fatigue or receives antihistamines to treat a local reaction, they should avoid driving until they know how the treatment affects them.
There is no direct chemical interaction between alcohol and Pinus Strobus Pollen. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of absorption of the extract or mask the early signs of an allergic reaction. It is generally advised to avoid alcohol for several hours after an injection.
Immunotherapy can be stopped at any time, but the benefits will likely be lost if the maintenance phase is not completed. There is no 'withdrawal syndrome' associated with stopping allergenic extracts.
> Important: Discuss all your medical conditions with your healthcare provider before starting Pinus Strobus Pollen.
There are no known food interactions that affect Pinus Strobus Pollen. However, patients with 'Oral Allergy Syndrome' (Pollen-Food Allergy Syndrome) may find that their sensitivity to certain raw fruits or vegetables increases slightly during the build-up phase of pine pollen immunotherapy.
There are no documented interactions with herbal supplements. However, patients should avoid any supplement that claims to 'boost the immune system' (such as Echinacea) without consulting their allergist, as these could theoretically interfere with the desensitization process.
For each major interaction, the mechanism is usually pharmacodynamic (affecting the body's response to the drug or the rescue medication) rather than pharmacokinetic (affecting metabolism).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Pinus Strobus Pollen must NEVER be used in the following circumstances:
Patients allergic to Pinus Strobus may show cross-reactivity with other members of the Pinaceae family, such as Spruce (Picea) or Fir (Abies). This means the skin test for Pinus Strobus might be positive even if the patient is primarily sensitized to a related tree. This is considered during the formulation of the treatment extract.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Pinus Strobus Pollen.
Pinus Strobus Pollen is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk is not the extract itself (which is a natural protein), but the potential for a systemic reaction in the mother. Anaphylaxis can cause a sudden drop in blood pressure and uterine contractions, leading to fetal distress or miscarriage.
It is not known whether the components of Pinus Strobus Pollen are excreted in human milk. However, because these are large proteins that are degraded at the injection site, it is highly unlikely they would reach the milk in any significant or harmful form. Breastfeeding is generally considered safe during immunotherapy.
As discussed, Pinus Strobus Pollen is used in children for both diagnosis and treatment. However, the risk-benefit ratio must be carefully weighed for children under 5 years old. The child must be cooperative enough for the injection and the 30-minute observation period. Pediatric patients should be monitored closely for 'late-phase' reactions that can occur several hours after the injection.
Patients over age 65 may have a higher prevalence of cardiovascular disease, which increases the risk of complications from immunotherapy. The decision to use Pinus Strobus Pollen in the elderly must be individualized, focusing on the severity of the allergy versus the patient's cardiac reserve.
No dosage adjustments are necessary. The allergenic proteins are not cleared by the kidneys in a way that would be affected by renal failure or dialysis.
No dosage adjustments are necessary. The liver is not the primary site of metabolism for these allergenic proteins.
> Important: Special populations require individualized medical assessment.
Pinus Strobus Pollen works through a process of 'immunological desensitization.' The extract contains the major and minor allergens of the Eastern White Pine. Upon injection, these allergens are taken up by dendritic cells and presented to T-lymphocytes. In an allergic individual, this usually results in a Th2 response. Immunotherapy induces a 'class switch' in B-cells from producing IgE to producing IgG4. IgG4 acts as a 'blocking antibody,' binding to the pollen proteins before they can reach the IgE on the surface of mast cells. Additionally, the treatment increases the production of Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-beta) by regulatory T-cells, which dampens the overall allergic inflammatory response.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Local Subcutaneous Absorption) |
| Protein Binding | N/A (Proteins are the active agents) |
| Half-life | N/A (Immunological effect lasts years) |
| Tmax | 20-30 minutes (for systemic absorption) |
| Metabolism | Local Proteolysis |
| Excretion | Lymphatic clearance |
Pinus Strobus Pollen extract is a sterile liquid containing the water-soluble proteins, carbohydrates, and phenols extracted from the pollen of Pinus strobus. It is often standardized by PNU (Protein Nitrogen Units), where 1 unit equals 0.01 micrograms of phosphotungstic acid-precipitable nitrogen. The extract is typically clear to light amber in color.
Pinus Strobus Pollen is a member of the 'Allergenic Extracts, Pollen' class. It is specifically a non-standardized extract, distinguishing it from standardized extracts like Grass or Ragweed, which have more precisely defined biological potency units.
Common questions about Pinus Strobus Pollen
Pinus Strobus Pollen is primarily used for the diagnosis and treatment of allergies to the Eastern White Pine tree. In a diagnostic setting, a healthcare provider uses a small amount of the extract for skin testing to see if a patient has an allergic reaction. For treatment, it is used in 'allergy shots' (immunotherapy) to help the body become less sensitive to the pollen over time. This is typically reserved for patients whose symptoms are not well-controlled by standard medications like antihistamines. It is not used to treat acute symptoms but rather as a long-term preventative measure.
The most common side effects are localized to the area where the injection was given. These include redness, swelling, itching, and a hard bump (wheal) at the injection site. These reactions usually appear within 20 minutes and fade within a day. Some patients may also experience mild tiredness or a temporary increase in their typical allergy symptoms. While these are common, they are generally not dangerous. However, any large or persistent swelling should be reported to your doctor.
It is generally advised to avoid alcohol for several hours before and after receiving a Pinus Strobus Pollen injection. Alcohol causes blood vessels to dilate, which can potentially speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic reaction. Furthermore, alcohol can mask the early symptoms of an allergic reaction, such as flushing or dizziness, making it harder to identify an emergency. Always follow the specific instructions provided by your allergy clinic regarding lifestyle restrictions. If you do consume alcohol, do so in moderation and only after the observation period has passed.
Pinus Strobus Pollen is generally not started during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the baby. If a woman is already on a stable maintenance dose of immunotherapy and is tolerating it well, many allergists will allow her to continue the treatment. However, the dose is usually not increased during pregnancy to minimize the risk of a reaction. Decisions regarding immunotherapy during pregnancy must be made on an individual basis by a healthcare provider. Always inform your allergist immediately if you become pregnant.
Immunotherapy with Pinus Strobus Pollen is a long-term commitment and does not provide immediate relief. Most patients begin to notice a reduction in their allergy symptoms during the first year of treatment, usually once they have reached the maintenance dose. Significant improvement is typically seen by the second year. To achieve long-lasting or permanent results, a full course of treatment lasting 3 to 5 years is usually required. If no improvement is seen after 12-18 months of maintenance therapy, your doctor may re-evaluate the treatment plan.
Yes, you can stop receiving Pinus Strobus Pollen injections at any time without experiencing withdrawal symptoms. Unlike some medications that require a tapering period, allergenic extracts do not cause physical dependence. However, if you stop the treatment before completing the recommended 3-5 year course, your allergy symptoms will likely return over time. If you miss several doses due to illness or travel, you should not simply resume at your previous dose; your doctor will need to adjust the dose downward for safety. Always discuss your plans with your allergist before discontinuing treatment.
If you miss a scheduled injection of Pinus Strobus Pollen, contact your allergy clinic as soon as possible to reschedule. Do not attempt to 'double up' on doses. If only a few days have passed, your doctor may give you your regular dose. However, if several weeks have passed, your immune system's tolerance may have decreased, and your doctor will likely need to reduce the dose for your next injection to prevent a reaction. Consistency is key to the success of immunotherapy, so try to stick to your schedule as closely as possible.
There is no clinical evidence to suggest that Pinus Strobus Pollen extracts cause weight gain. The extract consists of natural proteins and is administered in very small quantities that do not affect the body's metabolism or appetite. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as other medications (like oral steroids sometimes used for asthma) or lifestyle changes. If you have concerns about weight gain, discuss them with your primary care physician to identify the underlying cause.
Pinus Strobus Pollen can be taken with many common medications, but there are critical exceptions. You must avoid beta-blockers (used for blood pressure and heart conditions) because they can make allergic reactions more severe and prevent epinephrine from working in an emergency. Some antidepressants and ACE inhibitors may also increase risks. Interestingly, you may need to stop taking antihistamines before diagnostic skin testing, as they can cause false-negative results. Always provide your allergist with a complete list of all medications and supplements you are currently taking.
The concept of 'generic' vs. 'brand name' is different for allergenic extracts than for pills. Pinus Strobus Pollen is a biological product produced by several different laboratories (such as ALK, Greer, or HollisterStier). While the extracts are essentially the same active ingredient, they are 'non-standardized,' meaning there can be slight variations in potency between manufacturers. Therefore, allergists usually prefer to stick with the same manufacturer for the duration of a patient's treatment. These products are generally covered by insurance as biological allergy extracts.